Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: An observational cohort study
Annals of Internal Medicine Dec 01, 2017
Castle PE, et al. - Researchers strived to estimate the cervical cancer risk in routine practice after successive negative screening co-tests at 3-year intervals. Based on the findings, it was deduced that longer screening intervals (every 5 years or more) could be feasible and safe, after 1 or more negative cervical co-tests (or human papillomavirus (HPV) tests).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
